✦ LIBER ✦

Long-term follow-up of alpha-interferon treatment of patients with chronic hepatitis B

✍ Scribed by Monika van Zonneveld; Pieter Honkoop; Bettina E. Hansen; Hubertus G.M. Niesters; Sarwa Darwish Murad; Robert A. de Man; Solko W. Schalm; Harry L.A. Janssen

Publisher: John Wiley and Sons
Year: 2004
Tongue: English
Weight: 156 KB
Volume: 39
Category: Article
ISSN: 0270-9139
DOI: 10.1002/hep.20128

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term follow-up of patients with chr

Long-term follow-up of patients with chronic hepatitis C treated with α-interferon

✍ Michiko Shindo; Adrian M. di Bisceglie; Jay H. Hoofnagle 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 426 KB

We reanalyzed the results of a pilot study of recombinant alpha-interferon therapy for chronic non-A, non-B hepatitis in light of the recent discovery of the hepatitis C virus and the development of diagnostic assays for this agent. Stored serum samples from 10 patients treated between 1984 and 1986

Long-term follow-up of hepatitis B carri

Long-term follow-up of hepatitis B carrier children treated with interferon and prednisolone

✍ Elizabeth H. Boxall; Jaswant Sira; Anna L. Ballard; Paul Davies; Deirdre A. Kell 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB

The long-term outcome of treatment with Interferon Alpha 2B with and without Prednisolone priming in children infected perinatally with hepatitis B was reviewed. The group studied included 48 children (aged 2-16 years), who were HBe antigen and hepatitis B DNA positive between 1991 and 1993. Twenty

Long-term follow-up of anti-HBe-positive

Long-term follow-up of anti-HBe-positive chronic active hepatitis B

✍ Giovanna Fattovich; Lucio Brollo; Alfredo Alberti; Patrizia Pontisso; Giuliano G 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 444 KB 👁 1 views

Twenty-eight patients with chronic active hepatitis without cirrhosis who were positive for hepatitis B surface antigen and antibody to hepatitis B e antigen were followed for 1 to 15 years (mean 6.6 years) and underwent follow-up biopsy. At presentation, 12 of the 28 patients (43%) had hepatitis B

Long-term follow-up of peginterferon and

Long-term follow-up of peginterferon and lamivudine combination treatment in HBeAg-positive chronic hepatitis B

✍ Henry Lik-Yuen Chan; Alex Yui Hui; Vincent Wai-Sun Wong; Angel Mei-Ling Chim; Ma 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 141 KB 👁 1 views

We have previously demonstrated that combination peginterferon and lamivudine treatment has superior antiviral efficacy to lamivudine monotherapy in chronic hepatitis B. In this study, we investigated the long-term posttreatment virological response to this combination treatment. Sustained virologic

Evaluation of treatment and long-term fo

Evaluation of treatment and long-term follow-up in patients with hepatic alveolar echinococcosis

✍ Z. Kadry; E. C. Renner; L. M. Bachmann; N. Attigah; E. L. Renner; R. W. Ammann; 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB 👁 2 views

Long-term follow-up of hepatitis B virus

Long-term follow-up of hepatitis B virus carrier infants

✍ Cho-Yu Chan; Shou-Dong Lee; May-Ing Yu; Yuan-Jen Wang; Yang-Te Tsai; Kwang-Juei 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 437 KB

## Abstract One hundred twenty‐two hepatitis B surface antigen (HBsAg) carrier infants were followed‐up for 8–10 years. One hundred eleven had antibody to hepatitis B core antigen (anti‐HBc; 83 had been vaccinated) and the remaining 11 were without anti‐HBc (7 had been vaccinated). During the follo